CD8A and neoplasm: CD8+-targeted PET imaging of tumor-infiltrating T cells, such as 89Zr-Df-IAB22M2C and 89ZED88082A PET imaging, can monitor the complex dynamics of CD8+ T cells in the context of ICBs, and may predict early response to immunotherapy (28, 29).